Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
GenomeWeb
New Products Posted to GenomeWeb: Cytek Biosciences, Thermo Fisher Scientific, Bruker
March 10, 2023 -
BioNews, Inc.
AviadoBio acquires rights to gene therapies’ new delivery technology
March 9, 2023 -
Fierce Biotech
Capital Rx CEO: PBM industry needs to be repaired, not ditched
March 9, 2023 -
San Francisco Business Times
Cancer, biosimilar drug maker Coherus shedding more biotech jobs
March 9, 2023 -
Business Wire
CareStack’s All-in-One Dental Software Gets AI Upgrade with Pearl Partnership
March 9, 2023 -
PR Newswire
Centivo Partnership with the Business Health Care Group Reports More Effective Utilization of Health Benefits, Leading to 23 to 36 Percent Cost Savings for Employers and Health Plan Members
March 9, 2023 -
PR Newswire
Capital Rx is Now Part of the B Corp™ Movement, Reinforcing its Commitment to Advancing Equity in Pharmacy Benefits
March 8, 2023 -
Globenewswire
Cytek® Biosciences Introduces New 20-Color AML Panel
March 7, 2023 -
PR Newswire
Capital Rx Named to the Forbes Best Startup Employers 2023 List
March 7, 2023 -
Business Wire
Rallybio Announces Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
March 6, 2023 -
Business Wire
Bicara Therapeutics Announces Oversubscribed $108 Million Series B Financing to Advance Clinical-Stage Pipeline of Dual-Action Biologics to Treat Cancer
March 6, 2023 -
Business Wire
TandemAI Raises $35 Million in Series A Financing to Expand Integrated Computational and Wet Lab Solutions to Accelerate Drug Discovery
March 1, 2023 -
Business Wire
Third Annual Science2Startup (S2S)™ Symposium on May 3, 2023 Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors
February 28, 2023 -
Globenewswire
Denali Therapeutics Announces Presentations on Enzyme Transport Vehicle (ETV) Development Programs for MPS Diseases at the Upcoming WORLDSymposium™
February 15, 2023 -
Fierce Biotech
New biotech VC takes off with $520M and a flight deck stacked with big-name investors ready to serve
February 14, 2023 -
The Guardian
Girl with deadly inherited condition is cured with gene therapy on NHS
February 14, 2023 -
Precision Oncology News
Owkin-led Machine Learning Study IDs Possible Cancer Treatment Biomarkers Using Federated Model
February 14, 2023 -
Globenewswire
Verve Therapeutics Announces VERVE-101 Awarded Innovation Passport by the UK MHRA for the Treatment of Heterozygous Familial Hypercholesterolemia
February 14, 2023 -
PR Newswire
Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy
February 14, 2023 -
Globenewswire
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
February 13, 2023 -
PR Newswire
Capital Rx Earns Surescripts® Certification & SOC 2 Type 2 Report
February 10, 2023 -
Business Wire
Ensoma Announces Closing of Twelve Bio Acquisition
February 9, 2023 -
Endpoints News
The top 100 venture investors in biopharma today. Who’s staying at the deals table?
February 9, 2023 -
GlobeNewswire
Protenus is Top Performing Solution in Two Segments Based on 2023 Best in KLAS Report
February 8, 2023 -
GlobeNewswire
Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis
February 8, 2023 -
GlobeNewswire
Structure Therapeutics Announces Pricing of Upsized Initial Public Offering
February 2, 2023 -
The White House
The White House highlights Owkin and CancerLinQ collaboration as part of its Cancer Moonshot
February 2, 2023 -
PR Newswire
Capital Rx is Honored to be Named to the 2023 New York Digital Health 100
February 1, 2023 -
GlobeNewswire
Insilico Medicine Opens Largest AI-Powered Biotechnology Research Center in the Middle East
February 1, 2023 -
Business Wire
NOCD Completes Additional Funding in its Quest to End the OCD Crisis
January 31, 2023 -
GlobeNewswire
BenchSci Announces Launch of ASCEND™ – a First-of-its-Kind ‘Map’ of All Disease Biology that Aims to Transform Pharmaceutical Research
January 31, 2023 -
Business Wire
Rallybio Announces Appointment of Jonathan I. Lieber as Chief Financial Officer
January 31, 2023 -
Business Standard
Enzene Biosciences raises $50 million, aims to expand into global markets
January 30, 2023 -
Paradigm
Paradigm Launches with $203 Million to Rebuild the Clinical Research Ecosystem
January 27, 2023 -
PR Newswire
Stride Health Recognized As One of Built In’s Best Places to Work in 2023
January 26, 2023 -
PR Newswire
Benchling Bolsters Commitment to Security with Type 2 SOC 2
January 26, 2023 -
GlobeNewswire
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies
January 26, 2023 -
Business Wire
Firefly Health Welcomes Former Massachusetts Lt. Governor Karyn Polito to its Advisory Council
January 25, 2023 -
PR Newswire
Carrot Fertility Exceeds National Benchmarks for Fertility Success, Publishes New, Independently Validated Outcomes Study
January 18, 2023 -
Business Wire
Structure Therapeutics Appoints Industry Leaders Eric Dobmeier and Joanne Waldstreicher to its Board of Directors
January 18, 2023 -
PR Newswire
Jefferson County to Use Eleos Health’s Augmented Intelligence to Give Therapists More Time to Serve Those With Mental Illness
January 12, 2023 -
GlobeNewswire
Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target
January 10, 2023 -
PR Newswire
Community Services Group Taps Eleos Health for Augmented Intelligence Support in Behavioral Healthcare
January 10, 2023 -
GlobeNewswire
Insilico Medicine launches 6th generation Intelligent Robotics Lab to further accelerate its AI-driven drug discovery
January 5, 2023 -
Business Wire
X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership
January 5, 2023 -
Business Wire
Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines
January 5, 2023 -
GlobeNewswire
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
January 5, 2023 -
PR Newswire
Innovent Announces NMPA’s Breakthrough Therapy Designation for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Previous Treated Advanced Non-small Cell Lung Cancer
January 4, 2023 -
PR Newswire
Patina announces partnerships with major national Medicare Advantage plans, significantly expanding the reach of its unique primary care experience for adults 65+ in Philadelphia region
December 15, 2022 -
Business Wire
Rallybio Announces Publication of Data Highlighting the Ability of HPA-1a-Specific Antibodies to Prevent Alloimmunization in an Authentic Mouse Model of FNAIT
December 15, 2022 -
PR Newswire
Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer
December 15, 2022 -
PR Newswire
Alternative Bio Launches with USD 15M Series Seed Financing Led by Eight Roads Ventures with F-Prime Capital and Sequoia China Seed Fund
December 14, 2022 -
EZ Newswire
Immuneel Therapeutics Presents Early Data from India for Varnimcabtagene Autoleucel at ASH Annual Meeting
December 14, 2022 -
PR Newswire
ABK Biomedical Raises USD 30M in Series C Financing
December 6, 2022 -
GlobeNewswire
Pulmocide Raises $52 Million to Fund Additional Late-Stage Development of Opelconazole
December 6, 2022 -
GlobeNewswire
Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform Trial
December 5, 2022 -
GlobeNewswire
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022
December 2, 2022 -
GlobeNewswire
Beam Therapeutics Announces FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for BEAM-201
December 2, 2022 -
Endpoints
Rallybio, AbCellera form new partnership around antibodies for rare disease
December 1, 2022 -
GlobeNewswire
Protenus CTO Michael Baglio Wins Top Healthcare Tech CTO Award
November 29, 2022 -
Business Wire
NOCD Educates Record Number of People During 2022 OCD Awareness Month
November 23, 2022 -
PR Newswire
AllHealth Network Selects Eleos Health to Deliver In-Session Automation, Reducing Clinician Burden and Improving Care
November 22, 2022 -
PR Newswire
Adela’s Co-Founder & Chief Scientific Officer to Deliver Plenary Session at American Association for Cancer Research (AACR) Special Conference on Precision Prevention, Early Detection, and Interception of Cancer
November 15, 2022 -
Fierce Healthcare
SonderMind picks up neuroscience company Total Brain to build out data-driven mental healthcare
November 15, 2022 -
PR Newswire
Centivo’s Virtual Primary Care practice receives NCQA Patient-Centered Medical Home Recognition
November 15, 2022 -
PR Newswire
Capital Rx is Crowned Winner of the Fierce Healthcare Fierce Innovation Award
November 15, 2022 -
PR Newswire
RareCyte® selected for the Wellcome Leap In Utero program; will utilize its rare cell liquid biopsy platform to perform breakthrough research to decrease stillbirth rates worldwide
November 14, 2022 -
News wise
RareCyte® selected for the Wellcome Leap In Utero program; will utilize its rare cell liquid biopsy platform to perform breakthrough research to decrease stillbirth rates worldwide
November 14, 2022 -
GlobeNewswire
Denali Therapeutics Announces Phase 1/2 Study Single Dose Healthy Volunteer Data with TAK-594/DNL593 (PTV:PGRN) and Progression to Enrolling Participants with FTD-GRN
November 1, 2022 -
Business Wire
Turnstone Biologics Announces FDA Clearance of IND for TIDAL-01, a Next-Generation TIL Therapy for Solid Tumors
October 31, 2022 -
GlobeNewswire
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022 -
PR Newswire
Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 (Recombinant anti-Claudin18.2 Monoclonal Antibody-drug Conjugate) in Patients with Advanced Solid Tumors
October 30, 2022 -
GlobeNewswire
Prime Medicine Announces Closing of Upsized Initial Public Offering
October 24, 2022 -
Business Wire
Devoted Health Achieves Top 5 out of 5 Medicare Advantage Star Rating for Ohio HMO Plans in First Year of Eligibility
October 11, 2022 -
GlobeNewswire
BrainsWay and NOCD Launch Collaboration to Increase Awareness of OCD Treatments
October 11, 2022 -
Fierce Pharma
Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug, but commercial value uncertain
October 10, 2022 -
PR Newswire
AppliedVR Wins Q3 2022 Comparably Awards-recognized for Happiest Employees, Best Company Compensation, Best Work-Life Balance and Best Perks & Benefits
October 10, 2022 -
PR Newswire
The China NMPA Approved CYRAMZA® (ramucirumab) for the Treatment in Patients with Hepatocellular Carcinoma
October 9, 2022 -
PR Newswire
OSF HealthCare Partnering with US HealthVest on new behavioral health hospital
October 6, 2022 -
PR Newswire
New Mental Health Company Led by Consumer Brand Industry Veterans to Revolutionize Mental Health Care Delivery for Seniors
September 28, 2022 -
Business Wire
Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
September 28, 2022 -
PR Newswire
Elucidata Raises $16 Million Series A to Reimagine AI Infrastructure for the Life Sciences Industry
September 27, 2022 -
MedCity News
Prime Medicine spells out IPO plans for ‘word processor’ of gene editing
September 23, 2022 -
PR Newswire
NodThera Announces Positive Phase 1 Study Readouts for the NLRP3 Inflammasome Inhibitors NT-0796 and NT-0249
September 21, 2022 -
GlobeNewswire
Beam Therapeutics Presents First In Vivo Data Demonstrating Potential of Multiplex Base Editing Approach to Target Disease Drivers of Chronic Hepatitis B Infection
September 19, 2022 -
GlobeNewswire
RIGImmune Announces Acquisition of Antiviral Company Subintro and Concurrent Financing by F-Prime Capital
September 15, 2022 -
MobiHealthNews
Provider search firm Kyruus buys patient engagement company Epion Health
September 15, 2022 -
Fierce Biotech
AviadoBio selected by Fierce Biotech as a ‘Fierce 15’ 2022 winner
September 12, 2022 -
Business Wire
Artemis Health and Zerigo Health Announce Partnership to Help Employers and Health Plans Better Evaluate and Manage Chronic Autoimmune Skin Conditions
September 8, 2022 -
PR Newswire
Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development
September 7, 2022
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.